Literature DB >> 23212346

NonO binds to the CpG island of oct4 promoter and functions as a transcriptional activator of oct4 gene expression.

Yoojin Park1, Ja-Myong Lee, Min-Young Hwang, Gi-hoon Son, Dongho Geum.   

Abstract

We investigated the relationship between oct4 gene expression patterns and CpG sites methylation profiles during ES cell differentiation into neurons, and identified relevant binding factor. The oct4 gene expression level gradually declined as ES cell differentiation progressed, and the CpG sites in the oct4 proximal enhancer (PE) and promoter regions were methylated in concert with ES cell differentiation. An electro-mobility shift assay (EMSA) showed that putative proteins bind to CpG sites in the oct4 PE/promoter. We purified CpG binding proteins with DNAbinding purification method, and NonO was identified by liquid chromatography-mass spectrometry. EMSA with specific competitors revealed that NonO specifically binds to the conserved CCGGTGAC sequence in the oct4 promoter. Methylation at a specific cytosine residue (CC* GGTGAC) reduced the binding affinity of NonO for the recognition sequence. Chromatin immunoprecipitation analysis confirmed that NonO binds to the unmethylated oct4 promoter. There were no changes in the NonO mRNA and protein levels between ES cells and differentiated cells. The transcriptional role of NonO in oct4 gene expression was evaluated by luciferase assays and knockdown experiments. The luciferase activity significantly increased threefold when the NonO expression vector was cotransfected with the NonO recognition sequence, indicating that NonO has a transcription activator effect on oct4 gene expression. In accordance with this effect, when NonO expression was inhibited by siRNA treatment, oct4 expression was also significantly reduced. In summary, we purified NonO, a novel protein that binds to the CpG island of oct4 promoter, and positively regulates oct4 gene expression in ES cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212346      PMCID: PMC3887857          DOI: 10.1007/s10059-013-2273-1

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  47 in total

1.  PSF/p54(nrb) stimulates "jumping" of DNA topoisomerase I between separate DNA helices.

Authors:  T Straub; B R Knudsen; F Boege
Journal:  Biochemistry       Date:  2000-06-27       Impact factor: 3.162

2.  The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs.

Authors:  Z Zhang; G G Carmichael
Journal:  Cell       Date:  2001-08-24       Impact factor: 41.582

3.  A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element.

Authors:  Sharon Gidekel; Yehudit Bergman
Journal:  J Biol Chem       Date:  2002-07-10       Impact factor: 5.157

4.  Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture.

Authors:  Qi-Long Ying; Marios Stavridis; Dean Griffiths; Meng Li; Austin Smith
Journal:  Nat Biotechnol       Date:  2003-01-13       Impact factor: 54.908

5.  Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells.

Authors:  J Matthew Velkey; K Sue O'Shea
Journal:  Genesis       Date:  2003-09       Impact factor: 2.487

6.  Identification of the polypyrimidine tract binding protein-associated splicing factor.p54(nrb) complex as a candidate DNA double-strand break rejoining factor.

Authors:  Catherine L Bladen; Durga Udayakumar; Yoshihiko Takeda; William S Dynan
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

7.  Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development.

Authors:  Peili Gu; Bryan Goodwin; Arthur C-K Chung; Xueping Xu; David A Wheeler; Roger R Price; Cristin Galardi; Li Peng; Anne M Latour; Beverly H Koller; Jan Gossen; Steven A Kliewer; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 8.  PSF and p54(nrb)/NonO--multi-functional nuclear proteins.

Authors:  Yaron Shav-Tal; Dov Zipori
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

9.  Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.

Authors:  Marion B Sewer; Viet Q Nguyen; Ching-Jung Huang; Philip W Tucker; Norio Kagawa; Michael R Waterman
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

10.  p54nrb acts as a transcriptional coactivator for activation function 1 of the human androgen receptor.

Authors:  Ken Ishitani; Tasuku Yoshida; Hirochika Kitagawa; Hiroaki Ohta; Shiro Nozawa; Shigeaki Kato
Journal:  Biochem Biophys Res Commun       Date:  2003-07-04       Impact factor: 3.575

View more
  13 in total

1.  New proteomic insights on the role of NPR-A in regulating self-renewal of embryonic stem cells.

Authors:  Sameh Magdeldin; Tadashi Yamamoto; Ikuo Tooyama; Essam M Abdelalim
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

2.  RNA-binding proteins in pluripotency, differentiation, and reprogramming.

Authors:  Diana Guallar; Jianlong Wang
Journal:  Front Biol (Beijing)       Date:  2014-10

3.  Nono, a Bivalent Domain Factor, Regulates Erk Signaling and Mouse Embryonic Stem Cell Pluripotency.

Authors:  Chun Ma; Violetta Karwacki-Neisius; Haoran Tang; Wenjing Li; Zhennan Shi; Haolin Hu; Wenqi Xu; Zhentian Wang; Lingchun Kong; Ruitu Lv; Zheng Fan; Wenhao Zhou; Pengyuan Yang; Feizhen Wu; Jianbo Diao; Li Tan; Yujiang Geno Shi; Fei Lan; Yang Shi
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

4.  Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects.

Authors:  Dennis Mircsof; Maéva Langouët; Marlène Rio; Sébastien Moutton; Karine Siquier-Pernet; Christine Bole-Feysot; Nicolas Cagnard; Patrick Nitschke; Ludmila Gaspar; Matej Žnidarič; Olivier Alibeu; Ann-Kristina Fritz; David P Wolfer; Aileen Schröter; Giovanna Bosshard; Markus Rudin; Christina Koester; Florence Crestani; Petra Seebeck; Nathalie Boddaert; Katrina Prescott; Rochelle Hines; Steven J Moss; Jean-Marc Fritschy; Arnold Munnich; Jeanne Amiel; Steven A Brown; Shiva K Tyagarajan; Laurence Colleaux
Journal:  Nat Neurosci       Date:  2015-11-16       Impact factor: 24.884

5.  The DBHS proteins SFPQ, NONO and PSPC1: a multipurpose molecular scaffold.

Authors:  Gavin J Knott; Charles S Bond; Archa H Fox
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

6.  A conserved charged single α-helix with a putative steric role in paraspeckle formation.

Authors:  László Dobson; László Nyitray; Zoltán Gáspári
Journal:  RNA       Date:  2015-10-01       Impact factor: 4.942

7.  Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).

Authors:  Duyen H Pham; Chuan C Tan; Claire C Homan; Kristy L Kolc; Mark A Corbett; Dale McAninch; Archa H Fox; Paul Q Thomas; Raman Kumar; Jozef Gecz
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

8.  NonA and CPX Link the Circadian Clockwork to Locomotor Activity in Drosophila.

Authors:  Weifei Luo; Fang Guo; Aoife McMahon; Shalise Couvertier; Hua Jin; Madelen Diaz; Allegra Fieldsend; Eranthie Weerapana; Michael Rosbash
Journal:  Neuron       Date:  2018-07-26       Impact factor: 17.173

9.  Regulation of PCGEM1 by p54/nrb in prostate cancer.

Authors:  Tsui-Ting Ho; Jianguo Huang; Nanjiang Zhou; Ziqiang Zhang; Pratirodh Koirala; Xinchun Zhou; Fangting Wu; Xianfeng Ding; Yin-Yuan Mo
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

10.  NonO Is a Novel Co-factor of PRDM1 and Regulates Inflammatory Response in Monocyte Derived-Dendritic Cells.

Authors:  Kyungwoo Lee; Su Hwa Jang; Hong Tian; Sun Jung Kim
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.